Enhancer-driven gene regulatory network of human forebrain development provides insights into autism
Cell differentiation is orchestrated by transcription factors binding to enhancers, shaping gene regulatory networks that drive neuronal lineage specification. Deciphering these enhancer-driven networks in human forebrain development is essential for understanding the genetic basis of neurodevelopmental disorders. Through integrative epigenomic and transcriptomic analyses of human forebrain organoids derived from 10 male individuals with autism spectrum disorder and their neurotypical fathers, we construct a comprehensive enhancer-driven gene regulatory network of early neurodevelopment. This network reveals hierarchical regulatory layers upstream of neuronal cell fate genes, experimentally validated via CRISPR interference and loss-of-function analyses. A subnetwork links autism-associated transcriptomic alterations to opposite activities of the transcription factors FOXG1, BHLHE22, EOMES, and NEUROD2, driving increased or decreased excitatory neuron specification in (respectively) macrocephalic or normocephalic individuals with autism. These findings support the association of autism with disruption of enhancer-driven regulatory networks altering neuronal cell fate decisions in the developing fetal brain. The authors construct a gene regulatory network showing the potential role of specific enhancer elements in driving lineage imbalance in autism, explaining why forebrain organoids from autism probands show heterogeneity in the generation of excitatory neurons.
Authors
- Pamela E. Ventola (ORCID: https://orcid.org/0000-0002-8062-0626)
- Kevin Archer Pelphrey (ORCID: https://orcid.org/0000-0001-5407-2577)
- Livia Tomasini (ORCID: https://orcid.org/0000-0001-7144-6964)
- Feinan Wu (ORCID: https://orcid.org/0000-0002-4962-1874)
- Matthew P. Nelson (ORCID: https://orcid.org/0000-0001-7819-0922)
- Flora Maria Vaccarino (ORCID: https://orcid.org/0000-0003-2167-981X)
- Alexandre Jourdon (ORCID: https://orcid.org/0000-0002-6074-1498)
- Alexias Safi (ORCID: https://orcid.org/0000-0001-6381-4923)
- Kevin T. Hagy
- Michael Emmerson Ward (ORCID: https://orcid.org/0000-0002-5296-8051)
- Gregory E. Crawford (ORCID: https://orcid.org/0000-0001-6106-2772)
- Katarzyna Chawarska (ORCID: https://orcid.org/0000-0002-1445-6346)
- James C. McPartland (ORCID: https://orcid.org/0000-0002-2570-0746)
- Jeremy D. Schreiner (ORCID: https://orcid.org/0000-0003-0468-1387)
- Abhiram Natu (ORCID: https://orcid.org/0000-0002-6498-6134)
- Jessica Mariani (ORCID: https://orcid.org/0000-0003-3657-1748)
- Charlie A Gersbach
- Neal M. Nolan
- Davide Capauto (ORCID: https://orcid.org/0000-0003-2156-0165)
- Scott Norton (ORCID: https://orcid.org/0000-0002-1366-0628)
- Alexej S. Abyzov (ORCID: https://orcid.org/0000-0001-5405-6729)
- Daniel M. Ramos (ORCID: https://orcid.org/0000-0002-4041-5273)
- Anna M. Szekely (ORCID: https://orcid.org/0000-0003-2527-8968)
- Boxun Li (ORCID: https://orcid.org/0000-0002-4516-4418)
- Anahita Amiri (ORCID: https://orcid.org/0000-0003-2748-8475)
- Cindy Khanh Nguyen
Institutions
- National Institutes of Health (US)
- Mayo Clinic (US)
- Duke University (US)
- Yale University (US)
- NeuroDevelopment Center (US)
- National Institute of Neurological Disorders and Stroke (US)
- University of Virginia (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41467-026-79602-6
- Citations
- 2
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.91
Funders
- Simons Foundation
- Yale University
- National Institutes of Health
- National Institute of Mental Health
- National Human Genome Research Institute
- Division of Materials Research
- Yale Center for Clinical Investigation, Yale School of Medicine